Integrating Network Pharmacology and Metabolomics Study on Anti-rheumatic Mechanisms and Antagonistic Effects Against Methotrexate-Induced Toxicity of Qing-Luo-Yin
暂无分享,去创建一个
Xin Wang | Shao Li | Yang Liu | Yan Li | Shao Li | Jian Zuo | Yang Liu | Jian Zuo | Jing Ye | Qingfei Liu | Xin Wang | Yan Li | Qingfei Liu | Jing Ye
[1] Yoshiya Tanaka. Current concepts in the management of rheumatoid arthritis , 2016, The Korean journal of internal medicine.
[2] F. Ramalho,et al. Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis , 2017, Arthritis Research & Therapy.
[3] A. Bergen,et al. Cigarette smoking. , 1999, Journal of the National Cancer Institute.
[4] J. Smolen,et al. Developments in the clinical understanding of rheumatoid arthritis , 2009, Arthritis research & therapy.
[5] Shao Li,et al. Evidence-Based ZHENG: A Traditional Chinese Medicine Syndrome , 2012, Evidence-based complementary and alternative medicine : eCAM.
[6] Ji‐Won Kim,et al. Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity , 2016, Diabetes.
[7] G. Firestein,et al. Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.
[8] Zhaohui Wu,et al. Knowledge discovery in traditional Chinese medicine: State of the art and perspectives , 2006, Artif. Intell. Medicine.
[9] Bo Zhang,et al. Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.
[10] Na Lin,et al. Network Pharmacology-based Approaches Capture Essence of Chinese Herbal Medicines , 2016 .
[11] R. Abagyan,et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.
[12] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[13] A. Haschemi,et al. Time and Demand are Two Critical Dimensions of Immunometabolism: The Process of Macrophage Activation and the Pentose Phosphate Pathway , 2015, Front. Immunol..
[14] B. Cronstein,et al. Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis , 2005, Pharmacological Reviews.
[15] A. Nevill,et al. Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis , 2007, Annals of the rheumatic diseases.
[16] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[17] J. Seegmiller. Purine metabolism. , 1975, Arthritis and rheumatism.
[18] Shao Li,et al. Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury. , 2015, Journal of ethnopharmacology.
[19] Shao Li,et al. Suppressive effects of a Chinese herbal medicine qing-luo-yin extract on the angiogenesis of collagen-induced arthritis in rats. , 2003, The American journal of Chinese medicine.
[20] S. Chatterjee,et al. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study , 2016, Indian journal of pharmacology.
[21] N. Murphy. Current concepts in the management of rheumatoid arthritis. , 1992, Delaware medical journal.
[22] H. Mayan,et al. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients. , 2014, Autoimmunity reviews.
[23] Song-min Jiang,et al. Effects of berberine on human rheumatoid arthritis fibroblast-like synoviocytes , 2011, Experimental biology and medicine.
[24] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.
[25] Xin Wang,et al. Matrine Is Identified as a Novel Macropinocytosis Inducer by a Network Target Approach , 2018, Front. Pharmacol..
[26] Xuegong Zhang,et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. , 2007, IET systems biology.
[27] Frank Hsu,et al. Knowledge Discovery , 2014, Encyclopedia of Social Network Analysis and Mining.
[28] Bo Zhang,et al. An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin , 2013, Evidence-based complementary and alternative medicine : eCAM.
[29] Carlos M. Laborde,et al. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers. , 2015, Clinical and experimental rheumatology.
[30] J. Linden,et al. Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.
[31] C. Qi,et al. Sinomenine Versus NSAIDs for the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis , 2008, Planta medica.
[32] Joshua D. Rabinowitz,et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway , 2014, Biological reviews of the Cambridge Philosophical Society.
[33] Z. Qin,et al. TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway , 2015, Scientific Reports.
[34] A. Allison,et al. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). , 1996, Clinical transplantation.
[35] Chong-Zhi Wang,et al. Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthritis in rats. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[36] Jinzhi Lei,et al. Multiscale Modeling of Inflammation-Induced Tumorigenesis Reveals Competing Oncogenic and Oncoprotective Roles for Inflammation. , 2017, Cancer research.
[37] Hao Li,et al. Normalization and integration of large-scale metabolomics data using support vector regression , 2016, Metabolomics.
[38] Shao Li,et al. Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation , 2015, Scientific Reports.
[39] T Takahashi,et al. Traditional Chinese Medicine and Kampo: A Review from the Distant past for the Future , 2006, The Journal of international medical research.
[40] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[41] M. Sawyer,et al. Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus , 2012, World Journal of Surgical Oncology.
[42] N. Sato,et al. Mechanism of inhibitory action of ketone bodies on the production of reactive oxygen intermediates (ROIS) by polymorphonuclear leukocytes. , 1992, Life sciences.
[43] Shao Li. Mapping ancient remedies: Applying a network approach to traditional Chinese medicine , 2015 .
[44] Monica Guma,et al. Metabolomics in rheumatic diseases: desperately seeking biomarkers , 2016, Nature Reviews Rheumatology.
[45] Shiwen Zhao,et al. Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification , 2010, PloS one.